Drug Name Review Pilot Tailors Requirements For OTC Participants
This article was originally published in The Tan Sheet
Executive Summary
OTC drug manufacturers participating in FDA's trade name pilot will be required to include consumers in their simulation safety studies and review entire labels, not only product names
You may also be interested in...
Drug name review software loaded
FDA makes its Phonetic Orthographic Computer Analysis software program available for firms to check if a proposed new drug name looks or sounds like other product names or medical terminology, the agency says in a Feb. 17 Federal Register notice. The agency uses the software to identify look-alike or sound-alike drug names that could cause health care providers or patients to prescribe or use the wrong drug and cause an adverse event (1"The Tan Sheet" Oct. 27, 2008, p. 8)
Drug name review software loaded
FDA makes its Phonetic Orthographic Computer Analysis software program available for firms to check if a proposed new drug name looks or sounds like other product names or medical terminology, the agency says in a Feb. 17 Federal Register notice. The agency uses the software to identify look-alike or sound-alike drug names that could cause health care providers or patients to prescribe or use the wrong drug and cause an adverse event (1"The Tan Sheet" Oct. 27, 2008, p. 8)
Drug name review software loaded
FDA makes its Phonetic Orthographic Computer Analysis software program available for firms to check if a proposed new drug name looks or sounds like other product names or medical terminology, the agency says in a Feb. 17 Federal Register notice. The agency uses the software to identify look-alike or sound-alike drug names that could cause health care providers or patients to prescribe or use the wrong drug and cause an adverse event (1"The Tan Sheet" Oct. 27, 2008, p. 8)